Tilray Brands falls on missing Q3 revenue expectations
Shares of cannabis firm Tilray Brands TLRY.O down 3.2% at $0.58
Co reports Q3 rev. of $185.8 mln, missing analysts' estimate $210 mln, as per data compiled by LSEG
Says adj. EPS remained at $0.00 in both Q3 & comparative period
Adds, Tilray’s wellness business, Manitoba Harvest, is currently exempt from new tariffs
Co conducted an analysis of potential implications on its business concluding that these tariffs should not impact sales
TLRY revises fiscal year 2025 net revenue outlook to a range of $850 mln to $900 mln, down from previous estimate of $950 million to $1 billion
As of last close, stock down ~56.4% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
SpaceX IPO Guide: Can You Buy SpaceX IPO Shares on Robinhood? How Can Investors in Asia and Europe Buy SpaceX IPO Shares?

Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

Amazon Stock: 4 Pillars Supporting a Buy Thesis in a Cautious Market

Tradingkey








